Suven Life Sciences Limited

NSE:SUVEN.NS

128.96 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income -1,050.763-1,182.678-1,219.951-774.741-1,064.0081,587.4321,955.2591,230.705922.3611,515.5472,027.379328.52491.41832.54437.05550.96763.59107.55463.87324.06
Depreciation & Amortization 65.02258.26735.63735.24439.633256.941247.636276.462239.529242.12114.899104.66485.45379.05876.97271.42366.04840.13547.25541.036
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital 68.892114.807-39.273-147.044-1,028.931-845.932-923.70579.017-63.02682.433-572.641-187.35551.769-114.179-28.977106.215-129.564.567-65.171-69.468
Accounts Receivables -4.7864.9054.645.0863.738-37.167-157.04977.316-134.782253.011-489.548-151.16600000000
Inventory -7.0840.2241.191-1.41513.039-176.321-469.547-90.47-16.589-31.769-248.144-73.126-116.703-28.756-32.855-28.035-15.013-1.609-34.278-69.05
Accounts Payables 4.032-3.218-10.089-27.864-13.039-60.086188.76123.348-82.8600000000000
Other Working Capital 76.73112.896-35.015-122.851-1,032.669-572.358-454.158169.487-46.437114.202-324.497-114.229168.472-85.4233.878134.25-114.5476.176-30.893-0.418
Other Non Cash Items 226.961-21.878-51.783-73.695114.854-642.948-579.826-497.844-400.086-410.266-356.55661.024106.42757.73844.199114.12939.30610.1559.17725.479
Operating Cash Flow -827.77-1,031.482-1,275.37-960.236-1,938.452355.493699.3641,088.34698.7781,429.8341,213.081306.857335.06755.161129.249342.73439.384162.41155.13421.107
Investing Activities:
Investments In Property Plant And Equipment 1,156.274-28.948-197.716-63.047-23.851-975.589-417.927-305.358-578.626-1,182.935-378.81-200.691-272.749-40.354-48.267-115.089-194.274-201.6-133.49-131.066
Acquisitions Net 24.212-64.16411.1690-1,311.65400.26.987000000000000
Purchases Of Investments -268.327-1,047.818-447.2070-912.5250-0.292-3,008.36000000000-8.656-110.730
Sales Maturities Of Investments 06.148414.487918.5562,224.179696.974403.238200.544161.7810.0150.3480000026.7090138.54984.794
Other Investing Activites 859.974-1,471.672-3.025-297.1052,079.3680.0568.593-0.56627.80477.6721.91854.093-44.716-86.457-52.191-37.6075.5575.6711.19-17.606
Investing Cash Flow 615.859-2,606.454-222.292558.4042,055.517-278.559-6.096-3,106.753-389.041-1,105.25-356.544-146.598-317.465-126.811-100.458-152.696-162.008-204.586-94.481-63.878
Financing Activities:
Debt Repayment -8.956-4.843-8.523-6.924-32.932-64.48-244.581-93.848-218.357-182.623-341.291-128.374000000-43.14-41.911
Common Stock Issued 03,974.0461,476.417369.2000002,00001.995016.89103.4048.3036.85800
Common Stock Repurchased 00000000000000000000
Dividends Paid 00000-230.169-190.93-153.194-398.314-341.712-41.006-40.702-33.921-33.977-33.892-33.844-33.714-28.506-25-25
Other Financing Activities -1.584-13.812-10.978-13.7260.3569.531-386.05-147-300.172133.043-76.284192.61315.60595.8915.083-177.5180.653147.86695.4714.556
Financing Cash Flow -8.9563,955.3911,456.916348.55627.418-225.118-576.98-300.194-698.4861,791.331-382.29725.532-18.31678.804-18.809-207.9555.242126.21827.33-52.355
Other Information:
Effect Of Forex Changes On Cash 0000.001-0.002-0.001000.001000.003000-0.001000-0.001
Net Change In Cash 1,247.698317.455-40.746-53.275144.483-148.185116.288-2,318.607-388.7482,115.915474.24185.794-0.7147.1549.982-17.913-67.38284.043-12.017-95.127
Cash At End Of Period 1,639.795370.19152.73693.482146.758111.304203.16886.882,404.8712,793.619677.704203.46417.6729.46322.30912.32730.36997.75113.70925.726